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Lucy Spelman,2 Peter A. Barry,  
Michael R. Cranfield, and Linda J. Lowenstine
In 2007, we detected human herpes simplex virus type 
1,	which	caused	stomatitis,	in	a	juvenile	confiscated	eastern	
lowland gorilla (Gorilla beringei graueri)	that	had	a	high	de-
gree	of	direct	contact	with	human	caretakers.	Our	findings	
confirm	that	pathogens	can	transfer	between	nonhuman	pri-
mate hosts and humans.
Most emerging infectious diseases of humans are of wildlife origin (1). The close genetic relatedness 
of humans and nonhuman primates (NHPs) makes each 
uniquely susceptible to pathogens of the other (2). Spill-
over of NHP pathogens into humans can lead to human 
disease pandemics (e.g., HIV-1 from the chimpanzee 
strain of simian immunodeficiency virus [3]), and some 
NHP viruses are potentially acutely lethal to humans 
(e.g., herpes B virus of Asian macaques [4]). The opposite 
transmission event—human to NHP—is less frequently 
reported. Although of concern from a wildlife conserva-
tion standpoint (5), human-to-NHP transmission events 
substantiate the fact that pathogen sharing is bidirectional 
(6). To provide further evidence for the potential for dis-
ease emergence at the human–NHP interface, we report 
a human herpes simplex virus type 1 (HSV-1) infection 
in an eastern lowland gorilla (Grauer’s gorilla, Gorilla 
beringei graueri).
The Study
A 2-year-old female Grauer’s gorilla, confiscated 
from poachers in Goma, Democratic Republic of the 
Congo, in November 2005, was group-housed in a facil-
ity with 6 other juvenile Grauer’s gorillas and 1 juvenile 
mountain gorilla (G.b. beringei). All gorillas had daily 
direct contact with one another and with human caretak-
ers who provided hands-on care. In March 2007, 5 of the 
Grauer’s gorillas exhibited bouts of lethargy and anorexia 
and oral lesions. Three of the affected gorillas, including 
the gorilla from Goma, were chemically immobilized for 
examination. All 3 gorillas exhibited multiple clear fluid-
filled vesicles up to 2 cm in diameter that affected the mu-
cosa of the lips and gingiva (Figure 1, panel A). Biopsy 
and swab samples were obtained from the lesions of the 
gorilla from Goma. The biopsy sample was fixed in 10% 
buffered formalin; the swab samples were stored frozen at 
–80°C, and these specimens were shipped to the United 
States for diagnostic testing.
Histologic examination of the biopsy sample showed 
variably thickened, ulcerated, nonkeratinizing, strati-
fied squamous oral mucosae. Margins of ulcers showed 
marked epidermal swelling (intracellular edema, balloon-
ing degeneration) and large numbers of epithelial syncy-
tial cells, often with marginated chromatin and smudgy 
intranuclear inclusion bodies filling the nucleus (Figure 
1, panel B.). Inclusion bodies were present in individual 
cells in the stratum basalis and stratum spinosum adjacent 
to the ulcers. Using transmission electron microscopy, 
we observed virions consistent with herpesvirus in shape 
and size within the nucleus of syncytial cells and budding 
through the nuclear membrane (Figure 1, panel C.). His-
topathology and transmission electron microscopy find-
ings were essentially identical to findings from human 
HSV-1 infections (7).
DNA was extracted from swab samples from this ani-
mal (8) and amplified by PCR using pan-herpesvirus–spe-
cific primers designed to the DNA polymerase gene (UL30) 
(9). A cloned and sequenced 731-nt amplicon (GenBank 
accession no. KJ396198) showed 99% identities with the 
DNA and protein sequences of HSV-1 UL30, and 94% and 
95% identities (DNA and protein, respectively) to UL30 
of HSV-2 (Table). Because sequences from gorilla-specif-
ic herpesviruses have not been annotated, we performed 
a phylogenetic analysis of the amplicon from the gorilla 
swab sample using the UL30 genes from broadly repre-
sentative isolates from the 3 herpesvirus subfamilies. The 
gorilla-derived DNA and protein (Figure 2) exhibited the 
strongest phylogenetic relationship with HSV-1. Align-
ments of human and NHP alphaherpesvirus representa-
tives show that the region amplified with the consensus 
herpesvirus primers is a highly conserved region of UL30 
(Figure 2). The sequence alignments strongly suggested 
that the herpesvirus DNA in the oral lesion was HSV-1, 
although the gorilla-derived amplicon was an outlier in 
comparison with other HSV-1 isolates (data not shown). 
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The relative divergence of the amplicon was due primarily 
to nucleotide changes encoding a 3-aa motif not found in 
any other annotated sequence (Figure 2). Whether adapta-
tion of the putative HSV-1 in the gorilla host represents a 
compensatory change to replication in the ectopic gorilla 
host is not known.
To confirm our conclusion that the lesion was associ-
ated with HSV-1 infection, we used HSV-1–specific prim-
ers to amplify a region of UL30 (aa 134–246) outside of 
the amplicon defined by the pan-herpesvirus–specific prim-
ers. Amplification was positive for the oral swab sample 
DNA with this second primer pair and for 3 human-isolated 
HSV-1 strains. Sequence analysis of the amplicon demon-
strated 100% and 89% sequence identity with HSV-1 and 
HSV-2, respectively (data not shown).
Conclusion
On the basis of the results of the histopathologic fea-
tures and molecular screening of the virus, we concluded 
that the stomatitis in this juvenile female Grauer’s gorilla 
confiscated from poachers in Goma, Democratic Republic 
of the Congo, was caused by HSV-1. Alphaherpesvirus 
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Figure	1.	Vesicular	stomatitis	in	a	wild-caught	juvenile	Grauer’s	gorilla	(Gorilla beringei graueri).	Gross	lesions,	histopathologic	examination,	
transmission	electron	microscopy,	and	molecular	screening	confirmed	human	herpesvirus	type	1	(HSV-1)	as	the	etiologic	agent.	A)	Human	
HSV-1	lip	 lesions	in	a	wild-caught	 juvenile	Grauer’s	gorilla.	B)	Section	of	oral	mucosa	adjacent	to	a	vesiculo-ulcerative	 lesion	exhibits	
epithelial	cell	necrosis,	cytoplasmic	swelling,	nuclear	chromatin	margination	 (sometimes	with	discrete	Cowdry	 type	A	 inclusions),	and	
multinucleated	syncytia	typical	of	herpesviral	cytopathic	effects	(hematoxylin	and	eosin	stain).	Original	magnification	×200.	C)	Electron	
micrograph of the same lesion demonstrates intranuclear, unenveloped virions ≈100 nm in diameter that are budding through the nuclear 
membrane to form enveloped virions ≈140	nm	 in	diameter;	morphologic	 features	of	both	are	compatible	with	a	herpesvirus.	Original	
magnification	×60,000.	
 
Table. Comparison of gorilla amplicon to other herpesviruses* 
Gorilla	amplicon	identity HSV-1 HSV-2 MaHV-1 PaHV-2 HHV-3 HHV-4 HHV-5 HHV-6 HHV-8 EHV-1 
DNA,	% 99.3 93.6 85.3 86.0 53.9 61.2 49.3 43.3 48.6 65.1 
Protein, % 99.2 94.6 90.1 90.1 65.7 48.8 39.9 45.9 46.0 68.6 
*Pairwise	alignment	of	the	gorilla	amplicon	DNA	sequence	(GenBank	accession	no.	KJ396198)	and	predicted	amino	acid	sequence	of the corresponding 
region	of	HSV-1	(HHV-1;	AFI98948),	HSV-2	(HHV-2;	AGI44412),	MaHV-1	(AAT67222);	PaHV-2 (YP_443877),	HHV-3	(varicella	zoster	virus;	ABF21820),	
HHV-4	(Epstein-Barr	virus;	YP_401712),	HHV-5	(human	cytomegalovirus;	AAP37469),	HHV6	(BAF93477),	HHV-8	(Kaposi	sarcoma	virus;	ACY00400),	
and	EHV-1	(ADI96155).	DNA–DNA	alignments	were	performed	by	using	the Wilbur-Lipman	Method	of	the	MegAlign	(DNAStar,	Madison,	WI,	USA)	
sequence alignment program (Ktuple = 3;	gap	penalty = 3;	window = 20).	Protein–protein alignments were performed by using the Lipman-Pearson 
method (Ktuple = 2;	gap	penalty = 4;	gap	length	penalty = 12).	EHV,	equid	herpesvirus;	HSV,	herpes	simplex	virus;	HHV,	human	herpesvirus;	MaHV,	
Macacine herpesvirus;	PaHV,	Papiine	herpesvirus. 
 
HSV-1	in	Confiscated	Gorilla
exposure in wild gorillas in this region has been reported 
(10), but to our knowledge, human HSV infection in wild-
born captive gorillas has not been detected with molecu-
lar techniques. Fatal HSV-1 infection in a captive-born, 
nursery-reared western lowland gorilla (G. gorilla goril-
la) (11) has been reported. Serologic tests for HSV-1 on 
samples collected before the outbreak from other gorillas 
in the confiscated gorilla’s group showed that 2 clinically 
unaffected gorillas were seropositive for HSV-1, suggest-
ing previous exposure to an alphaherpesvirus (12). How-
ever, serologic tests for HSV-1 and -2 exposure in the 5 
clinically affected gorillas during this outbreak, includ-
ing the gorilla from Goma, were negative, which suggests 
these animals were experiencing their first HSV infec-
tions, and antibodies were not yet detectable. Although 
the HSV infection status of the poachers who captured 
and initially held the gorilla from Goma was unknown, 
as was the human HSV infection status of the caretakers 
(from whom samples were not collected) who had daily 
contact with this gorilla and her captive cohort, we can 
safely assume most of these persons were representative 
of the general human population and therefore infected 
because HSV-1 seropositivity has been documented at a 
prevalence of >90% in the region (13–15), and HSV in-
fections are lifelong.
Our findings have major ramifications for the possible 
reintroduction of these confiscated gorillas into the wild 
(all remain in captivity) because such a management action 
might introduce a novel (human) pathogen to a naïve popu-
lation. Screening wild Grauer’s gorillas and other gorilla 
populations for human HSV and other human pathogens 
will be critical to adequately assess the risk for reintroduc-
ing captive gorillas to wild populations of these endangered 
great apes. From a global health standpoint, our finding of 
human HSV-1 in a gorilla proves once again that pathogens 
transfer among human and NHP hosts.
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Figure	2.	Phylogenetic	analysis	of	the	nucleotide	sequence	(A)	and	predicted	amino	acid	sequence	(B)	from	the	swab	sample	amplicon	
from	the	gorilla	with	the	corresponding	regions	of	HSV-1	(HHV-1;	GenBank	accession	no.	AFI98948);	HSV-2	(HHV-2;	AGI44412);	MaHV-1	
(AAT67222);	PaHV-2	(YP_443877);	HHV-3	(varicella	zoster	virus;	ABF21820);	HHV-4	(Epstein-Barr	virus;	YP_401712);	HHV-5	(human	
cytomegalovirus;	AAP37469);	HHV-6	(BAF93477);	HHV-8	(Kaposi	sarcoma	virus;	ACY00400),	and	EHV-1	ADI96155).	Sequences	were	
aligned	 by	 the	Clustal	W	method	 (http://www.clustal.org)	 by	 using	 the	MegAlign	 (DNAStar,	Madison,	WI,	 USA)	 sequence	 alignment	
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